baber/WOPTO huggingface dataset:
Patent AU-2019213326-A1 (AU)
Title: Intelligent wireless communications for continuous analyte monitoring
Inventor: BURNETTE DOUGLAS WILLIAM
IPC: A61B5/15
Filed: 2019-08-06
Abstract: Various embodiments relate generally to continuous monitoring of analyte values received from an analyte sensor system. In some example embodiments, there is provided a method that includes receiving sensor information, calculating and storing estimated analyte measurement values based upon the received sensor information. The method also includes determining one or more communication conditions, and instructing a transceiver to advertise to a first display device in accordance with one or more communication variables based upon the one or more communication conditions. The method then transmits the estimated analyte measurement values to the at least first display device. Related systems, methods, and articles of manufacture are also described. 'ID IK' III' <½ a aN HI - N 7 PC.. TIk ---~-j:9*) #1~~K 1 \N ", kc N / 7 2 ft.. 1/ -~t.--. N" N'-.- "N 'C) ..~x/ K) - A 'C * N 'A N 'AN U) K)~v cc cc -~ '~. C) q U) (. *~2 -t ~) "S
Patent AU-2019216085-A1 (AU)
Title: Method for preparing natural L-cysteine crystals by continuous chromatography
Inventor: KIM JUN-WOO
IPC: C07C323/58
Filed: 2019-01-30
Abstract: The present disclosure relates to a method for preparing L-cysteine crystals, and L-cysteine crystals prepared by the method. Through the method for preparing L-cysteine crystals of the present disclosure, L-cysteine crystals can be obtained from a natural L-cysteine fermentation broth with a high recovery rate and/or purity without a chemical reaction or the use of an artificial synthetic compound.
Patent AU-2019220725-A1 (AU)
Title: Modified filter membrane and method
Inventor: LIU SHENGJIANG
IPC: C12N7/02
Filed: 2019-02-15
Abstract: The embodiments provide a modified filter membrane for separating a crude solution of a biological product and a viral contaminant. The filter membrane has a cellulosed based porous surface, and at least one divalent metal ion bound to the cellulose based porous surface of the filter membrane to form a modified filter membrane cellulose based porous surface, wherein the modified cellulose based porous surface separates the crude solution by retaining a viral contaminant greater than 15 nm in diameter while allowing a biological product smaller than 15 nm in diameter to pass through. The embodiments also provide a method of filtering a crude solution of a biological product and a viral contaminant using a modified filter membrane by adding a divalent metal ion to a filter membrane porous surface to form a modified filter membrane porous surface with a pore size in the range of 1 to 15 nm in size, and filtering the crude solution of the biological product and the viral contaminant through the porous surface of the modified filter membrane, wherein the modified filter membrane retains the viral contaminant on the porous surface while allowing the biological product to pass through.
Patent AU-2019240726-A1 (AU)
Title: Diffusion-Hardened Medical Implant
Inventor: PAWAR VIVEK
IPC: A61F2/28
Filed: 2019-10-07
Abstract: The present invention relates to a new composition and medical implant made therefrom, the composition comprising a thick diffusion hardened zone, and preferably further comprising a ceramic layer. The present invention relates to orthopedic implants comprising the new composition, methods of making the new composition, and methods of making orthopedic implants comprising the new composition.
Patent AU-2019244477-A1 (AU)
Title: Farber disease markers and uses thereof
Inventor: COQUERY CHRISTINE
IPC: G01N33/68
Filed: 2019-03-22
Abstract: Immune-phenotype markers for Farber disease and their uses are disclosed, as are methods of diagnosing and treating Farber disease based on these markers.
Patent AU-2019283910-A1 (AU)
Title: Quick-change system, adapter and quick coupler
Inventor: SCHMID SEBASTIAN
IPC: E02F3/36
Filed: 2019-12-19
Abstract: The invention relates to a quick-change system for changing attachments on a construction 
5 machine using an adapter (1) and a quick coupler (2) connectable to the adapter (1), in which 
the adapter (1) has at least a first coupling piece (15) and the quick coupler (2) has a second 
coupling piece (16) connectable to the first coupling piece (15). A replaceable intermediate 
piece (23) is arranged on the first coupling piece (15) provided with first electrical contact 
elements (18) and/or the second coupling piece (16) provided with second electrical contact 
0 elements (21) to produce an electrical connection between the first coupling piece (15) and 
the [second] coupling piece (16).  
Figure 1 
11946974_1 (GHMatters) P112552.AU
1/4 
Fig. 1 
2 
12 
10 
9 
414 
13 
4 16 15
Patent AU-2019299919-A1 (AU)
Title: Electrosurgical instrument
Inventor: HANCOCK CHRISTOPHER PAUL
IPC: A61B18/18
Filed: 2019-06-27
Abstract: An electrosurgical instrument for delivering microwave energy to biological tissue, in which a pair of conductive tuning elements are mounted in a radiating instrument tip to shape a microwave radiation profile of the instrument so that the radiation profile is constrained around the instrument tip. Such tuning elements may result in a radiation profile that is substantially spherical around the instrument tip, providing a well-defined ablation volume. The tuning elements act to improve the efficiency with which microwave energy can be delivered into target tissue
Patent AU-2019302442-A1 (AU)
Title: Directional electrical stimulation leads and systems for spinal cord stimulation
Inventor: HOWARD JOSHUA DALE
IPC: A61N1/36
Filed: 2019-07-05
Abstract: An implantable electrical stimulation lead can be used for spinal cord stimulation. Leads with segmented electrodes can be used to provide both medial and lateral stimulation. Multiple leads with segmented electrodes can provide paddle-like stimulation. Leads with bent distal portions can facilitate stimulation of multiple elements of the spinal cord and associated anatomy such as, for example, the dorsal column, dorsal, horn, dorsal root ganglia, and the like.
Patent AU-2019315790-A1 (AU)
Title: Valve and method
Inventor: STONE MATTHEW
IPC: E21B34/10
Filed: 2019-06-21
Abstract: A spring biased device having a plurality of operational spring rates including a housing; a first spring disposed between a selective support and a functional component; a second spring disposed between the selective support and another support; and a releasable connection between the selective support and the housing. A valve including a housing; a seat disposed within the housing; poppet movable to a position on the seat and a position off the seat, the poppet having a valve stem; a selective support; another support attached to the housing, the selective support and the another support allowing through passage of the valve stem; a first spring disposed between the selective support and the poppet; a second spring disposed between the another support and the selective support; and a connection between the selective support and the housing, the connection being selectively defeatible.
Patent AU-2019319750-A1 (AU)
Title: Compounds useful in modulating the farnesoid X receptor and methods of making and using the same
Inventor: SHARMA RAJIV
IPC: C07D261/18
Filed: 2019-08-06
Abstract: Provided are compounds that can act as a modulator of a farnesoid X receptor (FXR) and that can be useful in the treatment of diseases and/or disorders associated with the FXR. Compositions including such compounds are also provided along with methods for preparing compounds of the present invention and their use.
Patent AU-2019348974-A1 (AU)
Title: Synthetic methodfor the preparation of an alkoxymethylene-benzoylacetonitrile
Inventor: MEISENBACH MARK
IPC: C07C253/30
Filed: 2019-09-26
Abstract: Provided is a process for preparing a compound of Formula A (Formula A) or a salt or solvate thereof, the process comprising the step of: a) Reacting the compound 1 (1) with a trialkyl orthoformate to provide a compound of Formula A or a salt or solvate thereof, wherein R is the alkyl moiety of the trialkyl orthoformate. Further provided is the compound 2 or a salt or solvate thereof. (2) The use of these compounds in the synthesis of 3-[5-Amino-4-(3- Cyanobenzoyl)-Pyrazol-1-yl]-N-Cyclopropyl-4-Methylbenzamide is also provided.
Patent AU-2019367943-A1 (AU)
Title: Therapeutic medication for cartilage disorder
Inventor: TAMAI KATSUTO
IPC: A61K38/16
Filed: 2019-10-25
Abstract: The inventors of the present invention searched for a substance that is effective in treating a cartilage disorder, and as a result, found that, in an animal model of joint cartilage deficiency, an HMGB1 fragment peptide having a specific amino acid sequence exhibits the effect of reproducing a healthy cartilage tissue including a hyaline cartilage. Based on this finding, the present invention provides a pharmaceutical composition that contains the specific HMGB1 fragment peptide and that is for preventing and/or treating a cartilage disorder.
Patent AU-2019389876-A1 (AU)
Title: Surgical tool for positioning a surgical device, surgical device and kit
Inventor: KAITO TAKASHI
IPC: A61B17/70
Filed: 2019-11-21
Abstract: A surgical tool for positioning a surgical device comprising a gripping portion (2); a rod (3) protruding from the gripping portion (2) along a main development direction (X) of the tool up to a free end (3a) thereof; a coupling system (4) adapted to be coupled to the surgical device which can be engaged with a patient and operatively active at the free end (3a). The coupling system (4) comprises an axial retention assembly (5) comprising, at the free end (3a) of the rod (3), two opposite semispherical portions (6a, 6b), facing each other for the respective flat surfaces (7), separated from each other by an axial notch (8) made partially along the rod (3), and a central clutch (9) which is selectively movable between a locking position, in which the central clutch (9) approaches the free end (3a) of the rod (3) and interposed between the two semispherical portions (6a, 6b), preventing the reciprocal approach thereof so as to block the two semispherical portions (6a, 6b) within a seat of said surgical device (10).
Patent AU-2019411707-A1 (AU)
Title: Rotation apparatus and power generation system
Inventor: MIYAGAWA MEGUMI
IPC: H02K53/00
Filed: 2019-11-12
Abstract: ABSRRACT 
A rotation apparatus includes a first disk-shaped rotation 
body capable of rotating around a first rotation axis, a plurality 
of first permanent magnets arranged at a peripheral part of the 
first disk-shaped rotation body so that N-poles and S-poles thereof 
are distributed alternately, at least one pair of electromagnets 
arranged at static positions with a predetermined interval, the 
static positions being near the plurality of first permanent 
magnets, and a pair of sensor switches for respectively detecting 
rotationalpositions of the N-poles and the S-poles of the plurality 
of first permanent magnets and for electrically energizing the at 
least one pair of electromagnets. One electromagnet of the pair 
of electromagnets is energized based on a detected result of the 
pair of sensor switches to move the first permanent magnet adjacent 
to the energized electromagnet in a predetermined direction, by 
an attractive force and a repulsive force between the energized 
electromagnet and the first permanent magnet so as to rotate the 
first disk-shaped rotation body.
Patent AU-2019451025-A1 (AU)
Title: Optical filter based on light-matter coupling in quantum-confined cavity spaces
Inventor: KORUGA DJURO
IPC: B82Y40/00
Filed: 2019-06-12
Abstract: An optical filter may comprise a layer structure comprising a plurality of layers stacked in a thickness direction of the layer structure and including: a plurality of nano-photonic layers formed of a nano-photonic material with icosahedral or dodecahedral symmetry and at least one substrate layer formed of an optically transparent material, wherein one of the at least one substrate layer is positioned between two of the plurality nano-photonic layers in the thickness direction of the layer structure.
Patent AU-2019479051-A1 (AU)
Title: Composition and method for the treatment of type I diabetes
Inventor: NOVAK PETER
IPC: A61K31/223
Filed: 2019-12-20
Abstract: A method of treating type I diabetes comprising administering a therapeutically effective amount of
Patent WO-2021081593-A1 (WO)
Inventor: FOUNTAIN GRAHAM HARRY
IPC: F01B9/02
Filed: 2020-10-29
Abstract: L'invention concerne un moteur à combustion interne, comprenant un piston, un cylindre et un arbre de sortie, le piston étant conçu pour un mouvement de va-et-vient à l'intérieur du cylindre, entraîné par combustion, et le piston étant accouplé à l'arbre de sortie par un accouplement, de telle sorte que ledit mouvement de va-et-vient du piston entraîne la rotation de l'arbre de sortie, l'accouplement comprenant une tige de liaison accouplée au piston, un palier coulissant situé pour un mouvement de va-et-vient par rapport à la tige de liaison, l'accouplement comprenant en outre un vilebrequin monté rotatif à l'intérieur d'un palier coulissant, le moteur ayant un arbre à cames et un arbre d'équilibrage, l'arbre d'équilibrage étant logé dans un creux de l'arbre à cames, de telle sorte que l'arbre à cames et l'arbre d'équilibrage tournent autour d'un axe commun.
Patent AU-2020205609-A1 (AU)
Title: Quantification of sequencing instruments and reagents for use in molecular diagnostic methods
Inventor: ANGIUOLI SAMUEL V
IPC: G16B30/00
Filed: 2020-01-06
Abstract: The present disclosure provides a system and methods for receive a report from the diagnostic apparatus via the network interface for a testing parameter, the report comprising an identifier of a diagnostic apparatus generating the report, an identifier of a reagent used in the testing parameter, an identifier of software installed in the diagnostic apparatus, and a result of a testing parameter; determine whether the testing parameter is designated as a qualification run; when it is determined that the testing parameter is designated as a qualification run, the processor is further configured to: determine whether the software installed in the diagnostic apparatus is approved software by comparing the identifier of the software in the report with identifiers in memory, wherein when the software installed in the diagnostic apparatus is not approved, the associated status for the diagnostic apparatus is unqualified; examine the result of the testing parameter to determine whether the diagnostic apparatus or the reagent is qualified; and update the associated status. Embodiements also relate to a sequencing apparatus.
Patent AU-2020213272-A1 (AU)
Title: Insertion device for a biosensor and insertion method thereof
Inventor: HUANG CHUN-MU
IPC: A61B17/34
Filed: 2020-08-03
Abstract: INSERTION DEVICE FOR A BIOSENSOR AND INSERTION METHOD 
THEREOF 
An insertion device includes a cover body (12), an 
5 insertion module (30). The insertion module (30) is 
disposed in the cover body (12), and includes a main 
body (31), an insertion seat (33), a first elastic 
member (34), a retraction seat (35) and a second elastic 
member (37). When the cover body (12) is depressed, the 
10 insertion seat (33) is driven by the first elastic 
member (34) to perform an automatic-insertion 
operation and to collapse a limiting structure between 
the insertion seat (33) and the cover body (12). A 
limiting structure between the insertion seat (33) and 
15 the retraction seat (35) collapses upon the collapse 
of the limiting structure between the insertion seat 
(33) and the cover body (12), so that the retraction 
seat (35) is driven by the second elastic member (37) 
to perform an automatic-retraction operation.  
20 
(Figure 1)
L 
1116 
10(11) 
61 
112 13 
115 
60-, 12 
122 
125 125 
126 
126 
124 
303 30 
50 
225 
2242228 221 227 1227 
223_ 226 
20 
22 
222 21 FIG.1
Patent AU-2020220189-A1 (AU)
Title: Cochlear external device with external microphone
Inventor: MIN KYOU-SIK
IPC: A61N1/36
Filed: 2020-08-21
Abstract: ] 
A cochlear external device with an external microphone according to an 
embodiment of the present disclosure may include: an external device body attached 
to a side of the head of a user; an internal microphone embedded in the external 
5 device body to collect sound; an external microphone located at the outside of the 
external device body to be attached around the ear of the user to collect sound; a 
connection cable configured to connect the external microphone and the external 
device body in a wired manner; and a control unit embedded in the external device 
body to generate an output signal based on the sound collected by at least one of the 
0 internal microphone and the external microphone and transmit the generated output 
signal to a cochlear implant transplanter.
1/6 
[FIG. 1] 
110 100 
EXTERNAL DEVICE 
BODY 
120 INTERNAL 140 130 
MICRO PHONE 
151 PROCESSOR EXTERNAL 
150 _____ MICROPHONEE 
1 152 TRANSMITTER 
160 POWERSUPPLY 
UNIT 
[FIG. 2] 
110 100 
EXTERNAL DEVICE BODY 
120 INTERNAL 140 130 
MICRO PHONE 
170 CONTACT EXTERNAL 
SENSORPROCESSOR MICROPHONE 
180 VIBRATION TRANSMITTER 152 
160 POWER SUPPLY 
UNIT 
5
Patent AU-2020235037-A1 (AU)
Title: Aerosol provision device
Inventor: THORSEN MITCHEL
IPC: A24F40/465
Filed: 2020-03-09
Abstract: An aerosol provision device comprises a heater component configured to receive aerosol generating material, wherein the heater component is heatable by penetration with a varying magnetic field and an insulating member extending around the heater component, wherein the insulating member comprises a thermoplastic having a melting point greater than about 300ºC. The device further comprises at least one coil extending around the insulating member such that the insulating member is positioned between the at least one coil and the heater component, wherein the at least one coil is for generating the varying magnetic field.
Patent AU-2020252005-A1 (AU)
Title: Liposomal formulations, and methods of using and preparing thereof
Inventor: RAFALKO AGNES
IPC: A61P3/10
Filed: 2020-03-27
Abstract: The disclosure provides phosphorylated carbohydrate replacement therapies (CRT) that include compositions of phosphorylated carbohydrates and phospholipids, as well as methods for preparing such compositions. Such compositions are suitable for pharmaceutical delivery of phosphorylated carbohydrates to cell interior, endoplasmic reticulum, and Golgi, and can be used for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
Patent AU-2020258619-A1 (AU)
Title: JAK1 selective kinase inhibitor
Inventor: Qi changhe
IPC: C07D403/14
Filed: 2020-04-17
Abstract: Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, that are useful as JAK kinase inhibitors. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula (I), and methods of using such compounds or compositions to treat respiratory conditions (e.g., asthma or COPD).
Patent AU-2020276098-A1 (AU)
Title: Garment
Inventor: SHULTZ WILLIAM J
IPC: A41F1/00
Filed: 2020-05-13
Abstract: A garment is provided for selective attachment of support straps. The straps may be integrated into the garment or may separate therefrom. The straps may be used for support of the wearer. The straps may be used to customize and/or fit the garment to the wearer.
Patent AU-2020279753-A1 (AU)
Title: Transcutaneous electrical spinal cord neuromodulator and uses thereof
Inventor: GAD PARAG
IPC: A61N1/36
Filed: 2020-05-20
Abstract: In various embodiments electrical stimulators are provided for transcutaneous and/or epidural stimulation. In certain embodiments the stimulator provides one or more channels configured to provide one or more of the following stimulation patterns: i) monophasic electrical stimulation with a DC offset; ii) monophasic electrical stimulation with charge balance; iii) delayed biphasic electrical stimulation with a DC offset; iv) delayed biphasic electrical stimulation with charge balance; v) amplitude modulated dynamic stimulation; and/or vi) frequency modulated dynamic stimulation.
Patent AU-2020284110-A1 (AU)
Title: Neuroactive steroids and compositions thereof
Inventor: SALITURO FRANCESCO G
IPC: C07J11/00
Filed: 2020-05-29
Abstract: Provided herein is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R
Patent AU-2020304796-A1 (AU)
Title: Inhibitor of surface protein (SP-D) / SIRPα / SHP2 pathway for use in the prevention and/or treatment of secondary infection
Inventor: ROQUILLY ANTOINE
IPC: A61P31/06
Filed: 2020-06-23
Abstract: The invention relates inhibitor of surface protein D (SP-D) and/or inhibitor of SP-D-SIRPα interaction for use in the prevention and/or the treatment of secondary disease, in particular nosocomial disease. The present invention also relates to pharmaceutical composition comprising inhibitor of surface protein D (SP-D) and/or inhibitor of SP-D-SIRPα interaction for use in the treatment of secondary infection. The present invention finds application in the therapeutic and diagnostic medical technical fields.
Patent AU-2020320349-A1 (AU)
Title: Anti-EGFR/anti-4-1BB bispecific antibody and use thereof
Inventor: YONG YERYOUNG
IPC: C07K16/28
Filed: 2020-07-27
Abstract: Provided are an anti-4-1BB/anti-EGFR bispecific antibody, and a pharmaceutical composition and a method for treating and/or preventing a cancer using the same.
Patent AU-2020330133-A1 (AU)
Title: Extracellular vesicle-ASO constructs targeting CEBP/beta
Inventor: BURZYN DALIA
IPC: A61K31/7125
Filed: 2020-08-14
Abstract: The present disclosure relates to extracellular vesicles, e.g., exosomes, comprising an antisense oligonucleotide (ASO), wherein the ASO comprises a contiguous nucleotide sequence of 10 to 30 nucleotides in length that is complementary to a nucleic acid sequence within a CEBP/ transcript. Also provided herein are methods for producing the exosomes and methods for using the exosomes to treat and/or prevent diseases or disorders.
Patent AU-2020353080-A1 (AU)
Title: An integrated acute central venous catheter and peripherally inserted venous catheter
Inventor: HOWELL GLADE HAROLD
IPC: A61M39/06
Filed: 2020-09-24
Abstract: A catheter assembly includes a peripheral intravenous ("PIV") portion that provides expedited vascular access. The catheter assembly includes an elongate catheter body defining a first lumen and includes a CVC portion, a transition portion, and a PIV portion. The PIV portion defines a relatively smaller diameter, a tapered tip, and a lumen configured to receive a needle. The needle extends through a needle access aperture, disposed through a side wall of the catheter body, through the PIV lumen, to a point beyond a distal end of the catheter body. A clinician accesses a vasculature using the needle and the PIV portion. The needle is then removed and a guidewire advanced through the lumen of the catheter body and the PIV portion into the vasculature. The CVC portion is then advanced over the guidewire into the vasculature, self-dilating the insertion site as the transition portion enters the vasculature.
Patent AU-2020380828-A1 (AU)
Title: WDR5 inhibitors and modulators
Inventor: LEE TAEKYU
IPC: A61K31/47
Filed: 2020-11-08
Abstract: Isoquinolmone compounds and derivatives inhibit WDR5 and associated protein-protein interactions, and the compounds and their pharmaceutical compositions are useful for treating disorders and conditions in a subject, such as cancer cell proliferation.
Patent AU-2020401223-A1 (AU)
Title: Compositions and methods for substituted 7-(piperazin-1-yl)pyrazolo[1,5-a]pyrimidine analogs as inhibitors of KRAS
Inventor: PAGBA CYNTHIA V
IPC: A61K31/506
Filed: 2020-12-10
Abstract: In one aspect, the disclosure relates to compounds useful as inhibitors of mutant KRAS proteins, methods of making the same, pharmaceutical compositions comprising the same, and methods of treating cancers associated with mutated forms of KRAS using the same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.